Xizang Haisco Pharmaceutical Group Co Ltd (002653) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥39.68 Million ≈ $5.81 Million USD) by net assets (CN¥4.23 Billion ≈ $618.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Xizang Haisco Pharmaceutical Group Co Lt defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Xizang Haisco Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Xizang Haisco Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Xizang Haisco Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Xizang Haisco Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Transsion Holdings Co Ltd
SHG:688036
|
0.157x |
|
Waaree Energies Limited
NSE:WAAREEENER
|
0.038x |
|
Puig Brands SA
MC:PUIG
|
0.241x |
|
Maxscend Microelectronics Co Ltd
SHE:300782
|
-0.021x |
|
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM
|
-0.075x |
|
Masimo Corporation
NASDAQ:MASI
|
0.084x |
|
FSN E-Commerce Ventures Limited
NSE:NYKAA
|
0.086x |
|
PayPay Corporation American Depository Shares
NASDAQ:PAYP
|
1.056x |
Annual Cash Flow Conversion Efficiency for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Xizang Haisco Pharmaceutical Group Co Lt (002653) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.29 Billion ≈ $627.44 Million |
CN¥786.00 Million ≈ $115.02 Million |
0.183x | +74.26% |
| 2024-12-31 | CN¥4.20 Billion ≈ $614.92 Million |
CN¥442.05 Million ≈ $64.69 Million |
0.105x | -2.42% |
| 2023-12-31 | CN¥4.17 Billion ≈ $610.28 Million |
CN¥449.58 Million ≈ $65.79 Million |
0.108x | +257.25% |
| 2022-12-31 | CN¥3.13 Billion ≈ $458.49 Million |
CN¥94.55 Million ≈ $13.84 Million |
0.030x | +146.13% |
| 2021-12-31 | CN¥2.92 Billion ≈ $427.32 Million |
CN¥35.80 Million ≈ $5.24 Million |
0.012x | -83.03% |
| 2020-12-31 | CN¥2.85 Billion ≈ $417.74 Million |
CN¥206.21 Million ≈ $30.17 Million |
0.072x | -77.54% |
| 2019-12-31 | CN¥2.38 Billion ≈ $347.78 Million |
CN¥764.26 Million ≈ $111.84 Million |
0.322x | +35.70% |
| 2018-12-31 | CN¥1.99 Billion ≈ $291.83 Million |
CN¥472.61 Million ≈ $69.16 Million |
0.237x | +19.17% |
| 2017-12-31 | CN¥1.97 Billion ≈ $288.32 Million |
CN¥391.81 Million ≈ $57.33 Million |
0.199x | +9.11% |
| 2016-12-31 | CN¥2.25 Billion ≈ $328.53 Million |
CN¥409.20 Million ≈ $59.88 Million |
0.182x | -11.28% |
| 2015-12-31 | CN¥2.16 Billion ≈ $315.58 Million |
CN¥443.03 Million ≈ $64.83 Million |
0.205x | -13.86% |
| 2014-12-31 | CN¥2.11 Billion ≈ $308.37 Million |
CN¥502.57 Million ≈ $73.54 Million |
0.238x | -19.15% |
| 2013-12-31 | CN¥1.93 Billion ≈ $281.97 Million |
CN¥568.41 Million ≈ $83.18 Million |
0.295x | +8.40% |
| 2012-12-31 | CN¥1.71 Billion ≈ $249.91 Million |
CN¥464.75 Million ≈ $68.01 Million |
0.272x | -19.89% |
| 2011-12-31 | CN¥767.76 Million ≈ $112.35 Million |
CN¥260.79 Million ≈ $38.16 Million |
0.340x | -58.11% |
| 2010-12-31 | CN¥453.09 Million ≈ $66.30 Million |
CN¥367.38 Million ≈ $53.76 Million |
0.811x | -70.23% |
| 2009-12-31 | CN¥135.17 Million ≈ $19.78 Million |
CN¥368.21 Million ≈ $53.88 Million |
2.724x | +519.97% |
| 2008-12-31 | CN¥214.95 Million ≈ $31.45 Million |
CN¥94.45 Million ≈ $13.82 Million |
0.439x | -- |
About Xizang Haisco Pharmaceutical Group Co Ltd
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical products in the areas of anesthesia and analgesic, endocrine system, enteral parenteral nutrition, cardiovascular, psychiatric, tumor-related, digestive liver, and other diseases. Haisco Pharmaceutical Group Co., Ltd. has licensing and research c… Read more